ADHD guidelines for Australian general practitioners - clinical fact sheet and MCQ
Overview
The Australian Clinical Practice Guideline for ADHD provides evidence-based recommendations for diagnosing, managing, and supporting individuals with ADHD, tailored to the Australian context. Developed by the Australasian ADHD Professionals Association (AADPA), the guideline emphasises person-centred, multidisciplinary approaches to improve quality of life for the over one million Australians affected.
Identification and diagnosis of ADHD
Universal screening for ADHD is not recommended. However, clinicians should remain vigilant for ADHD in populations with a high prevalence which include individuals with a history of ADHD in immediate relatives, those with neurodevelopmental conditions, or those in correctional facilities (see Guideline for full list).
It is important to be aware that ADHD is often under-recognised in females.
Diagnosis requires a comprehensive assessment, incorporating clinical and psychosocial assessment, developmental and medical history, observer reports, and the use of validated criteria (DSM-5, ICD-10/11) by an appropriately trained clinician. Comorbid conditions, such as anxiety or substance use disorders, should be carefully evaluated.
Treatment of ADHD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreMedcast Medical Education Team
From 1 Nov 2025, the Australian government is making important changes with the Bulk Billing Practice Incentive Program (BBPIP). This FastTrack is a concise summary of how to make the most of the BBPIP, from registration, eligibility considerations, and a step-by-step approach to preparing your practice for the changes.
Medcast Medical Education Team
Two of the four core palliative care medicines are clonazepam and haloperidol, used respectively to manage anxiety and emesis in end-of-life patients. This FastTrack highlights the role of the GP in treating these two common symptoms, focusing on pharmacological strategies. 30mins each of RP and EA CPD available with the quiz.
Medcast Medical Education Team
Iron deficiency is the most common nutritional disorder around the world, affecting a disproportionate number of women. This FastTrack provides a concise summary of iron replacement in pre-menopausal women, with specific attention to menstruation and pregnancy-related iron deficiency. 30mins each of RP and EA CPD available with the quiz.